ORPHA:84
Fanconi anemia
Also known as: Fanconi pancytopenia
Publications
82,577
99.5th percentile
Trials
67
Interventional, condition-specific
Researchers
1,743
Distinct authors in sample
Gene link
BRIP1, FANCM
Definitive
Readiness
5/6
Stages with a signal
Clinical definition (Orphanet)
A rare genetic multisystem disorder characterized by pancytopenia with bone marrow failure, variable malformations and predisposition to develop hematological or solid tumors.
How rare: 1-9 / 100 000 — about one to nine people per hundred thousand.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0019391
- MeSH:D005199
- UMLS:C0015625
- NCIT:C62505
Additional Mondo synonyms (4)
Fanconi's anemia · Panmyelopathy, Fanconi · pancytopenia, congenital · primary erythroid hypoplasia
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
5/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedPresent
Definitive — BRIP1, FANCM
- LiteraturePresent
82,577 matched papers (59,186 in last 10 years) Source
- Phenotype characterisedPresent
668 HPO annotations (e.g. Preaxial hand polydactyly; Strabismus; Horseshoe kidney) Source
- Animal modelPresent
16 genotype models (Danio rerio, Mus musculus) Source
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPresent
67 matched on ClinicalTrials.gov (8 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Yes — we know a specific gene responsible (BRIP1, FANCM).
GenCC classification: Definitive.
Phenotypes (Monarch / HPO)
668
Associated phenotypes · MONDO:0019391
- Preaxial hand polydactyly
- Strabismus
- Horseshoe kidney
- Duplicated collecting system
- Cafe-au-lait spot
Showing 5 of 668 — open Monarch for the full list.
Animal models (Monarch / Alliance)
16
Model associations linked to this Mondo ID
- fancahg41/hg41 (NHGRI-1)·ZFIN:ZDB-FISH-240716-9·Danio rerio
- Fancctm1Mab/Fancctm1Mab [background:] involves: 129S1/Sv * 129X1/SvJ * C57BL/6J·MGI:2450130·Mus musculus
- rad51sa23805/sa23805·ZFIN:ZDB-FISH-180216-10·Danio rerio
- rad51chg65/hg65 (NHGRI-1)·ZFIN:ZDB-FISH-240716-10·Danio rerio
- Fancctm1Mgo/Fancctm1Mgo [background:] involves: 129S4/SvJaeSor * C57BL/6·MGI:2450132·Mus musculus
- Fancd2tm1Hou/Fancd2tm1Hou [background:] 129S4/SvJae-Fancd2tm1Hou·MGI:2673460·Mus musculus
- Aldh2tm1a(EUCOMM)Wtsi/Aldh2tm1a(EUCOMM)Wtsi Fancd2tm1Hou/Fancd2tm1Hou [background:] involves: 129S4/SvJae * C57BL/6J * C57BL/6N·MGI:5467971·Mus musculus
- Fancd2em1Tzh/Fancd2em1Tzh [background:] C57BL/6-Fancd2em1Tzh·MGI:6392094·Mus musculus
- Fancatm1Wong/Fancatm1Wong [background:] involves: C57BL/6·MGI:3047131·Mus musculus
- Fancatm1Faw/Fancatm1Faw [background:] involves: 129P2/OlaHsd * FVB·MGI:3618892·Mus musculus
- Fancd2tm1Hou/Fancd2tm1Hou [background:] involves: 129S4/SvJae * C57BL/6J·MGI:2673461·Mus musculus
- Fancatm1.1Wong/Fancatm1.1Wong [background:] involves: C57BL/6·MGI:3047099·Mus musculus
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
28
Drugs / clinical candidates · MONDO_0019391
- ALEMTUZUMAB·phase 2
- ANTILYMPHOCYTE IMMUNOGLOBULIN (HORSE)·phase 2
- BUSULFAN·phase 2
- CYCLOSPORINE·phase 2
- ELTROMBOPAG·phase 2
- FILGRASTIM·phase 2
- FLUDARABINE PHOSPHATE·phase 2
- MELPHALAN·phase 2
- METFORMIN·phase 2
- MOZAFANCOGENE AUTOTEMCEL·phase 2
- PLERIXAFOR·phase 2
- TACROLIMUS·phase 2
- OXANDROLONE·phase 1
- QUERCETIN·phase 1
- ALEFACEPT·unknown
CTD chemicals (MyDisease.info)
11 associated chemicals · 103 pathways. Therapeutic evidence is listed first when present — not a treatment recommendation.
- Adrenal Cortex Hormones · therapeutic
- Anabolic Agents · therapeutic
- Androgens · therapeutic
- Fluoxymesterone · therapeutic
- Methandrostenolone · therapeutic
- Nandrolone Decanoate · therapeutic
- Resveratrol · therapeutic
- Rutin · therapeutic
- tempol · therapeutic
- diepoxybutane · marker/mechanism
- Glutathione · marker/mechanism
Pathways: Antifolate resistance; Homologous recombination; Fanconi anemia pathway; MAPK signaling pathway; Cytokine-cytokine receptor interaction; NF-kappa B signaling pathway; Sphingolipid signaling pathway; Ubiquitin mediated proteolysis
Literature
Is anyone studying this?
82,577
82,577 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
82,577 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
59,186 in the last 10 years · high confidence · 99.5th percentile (publications denominator)
Phrase hits: 80,348 · MeSH hits: 0
Who's working on it?
1,743
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Crismani W5 papers · 2026
DNA Repair and Recombination Laboratory, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia.
Papers in Europe PMC - 02Zhang J5 papers · 2026
Department of Pathology and Laboratory Medicine, Mayo Clinic, Arizona Campus, Phoenix, AZ, United States.
Papers in Europe PMC - 03Zhang X5 papers · 2026
College of Medicine, Zhejiang University, Hangzhou 310058, China.
Papers in Europe PMC - 04Deans AJ4 papers · 2026
St Vincent's Institute of Medical Research, Fitzroy, VIC, Australia.
Papers in Europe PMC - 05Li J4 papers · 2025
Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China; Department of Pathology and Institute of Molecular Pathology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China. Electronic address: lijming3@sysu.edu.cn.
Papers in Europe PMC - 06Liu L4 papers · 2026
Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu, Nanjing, China.
Papers in Europe PMC - 07Wang J4 papers · 2026
Life Sciences Institute, Zhejiang University, Hangzhou, China.
Papers in Europe PMC - 08Wang X4 papers · 2026
Life Sciences Institute, Zhejiang University, Hangzhou, China.
Papers in Europe PMC - 09Wang Y4 papers · 2026
Center for Chromosome Stability, Department of Cellular and Molecular Medicine, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen N, Denmark.
Papers in Europe PMC - 10Bhattacharya D3 papers · 2026
Department of Biochemistry, Indian Institute of Science, Bangalore 560012, India.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
67
interventional trials for this specific condition
67 interventional trials matched this specific condition name; 8 currently recruiting in our sample. 2,047 trials are registered for anemia, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 11 September 2026 · last trial check 28 July 2026
67 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 97.9th percentile).
high confidence · 97.9th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
67 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT02143830·RECRUITING·HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
Not reviewed·Conditions: Fanconi Anemia · Severe Marrow Failure · Myelodysplastic Syndrome (MDS) · Acute Myelogenous Leukemia (AML)·Matched via name phrase
- NCT03579875·RECRUITING·Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders
Not reviewed·Conditions: Fanconi Anemia · Severe Aplastic Anemia · Myelodysplastic Syndromes · T Cell Receptor Alpha/Beta Depletion·Matched via name phrase
- NCT07408583·NOT YET RECRUITING·Prenatal Transplantation for Fetuses With Fanconi Anemia
Not reviewed·Conditions: Fanconi Anemia · Anemia, Hypoplastic, Congenital · Congenital Bone Marrow Failure Syndromes · Bone Marrow Failure Disorders·Matched via name phrase
- NCT05973656·RECRUITING·Role of Acetaldehyde in the Development of Oral Cancer
Not reviewed·Conditions: Alcohol-Related Carcinoma · Fanconi Anemia · Oral Cavity Carcinoma·Matched via name phrase
- NCT03351868·RECRUITING·FANCA Gene Transfer for Fanconi Anemia Using a High-safety, High-efficiency, Self-inactivating Lentiviral Vector
Not reviewed·Conditions: Fanconi Anemia·Matched via name phrase
- NCT04232085·RECRUITING·Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures
Not reviewed·Conditions: Primary Immune Deficiency Disorder · Immune Deficiency Disease · Bone Marrow Failure · Short Telomere Length·Matched via name phrase
- NCT04784052·RECRUITING·Depleted Donor Stem Cell Transplant in Children and Adults With Fanconi Anemia After Being Conditioned With a Regimen Containing Briquilimab
Not reviewed·Conditions: Fanconi Anemia·Matched via name phrase
- NCT06648096·RECRUITING·Afatinib in Patients With Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
Not reviewed·Conditions: Fanconi Anemia · Head and Neck Squamous Cell Carcinoma·Matched via name phrase
Broader category: anemia
2,047
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT06946394·NOT YET RECRUITING·Two Different Regiments of Pegmolesatide for Anemia in Patients With Chronic Kidney Disease Not Receiving Dialysis
Not reviewed·Conditions: Renal Anemia in Non-dialysis Chronic Kidney Disease·Matched via name phrase
- NCT06742528·RECRUITING·Comparison Of Efficacy Of Iron Polymaltose Complex And Ferrous Sulphate In Iron Deficiency Anemia In Pediatric Patients
Not reviewed·Conditions: Iron Deficiency Anemia · Iron Deficiency, Anaemia in Children·Matched via name phrase
- NCT07119372·RECRUITING·Study of the Efficacy and Safety of BCD-131 and Mircera® in the Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
Not reviewed·Conditions: Anemia · Chronic Kidney Disease · Chronic Kidney Disease Patients on Hemodialysis · Chronic Kidney Disease 5D·Matched via name phrase
- NCT07563582·RECRUITING·Efficacy of Oral Sucrosomial Iron Supplementation in Children With Celiac Disease and Iron Deficiency or Anemia
Not reviewed·Conditions: Celiac Disease in Children · Anemia · Iron Deficiencies·Matched via name phrase
- NCT04869683·RECRUITING·Biocollection in MyeloDysplastic Syndrome (P-MDS)
Not reviewed·Conditions: Myelodysplastic Syndromes · Myelodysplastic Anemia · Myelodysplastic Syndrome With Isolated Del(5Q) · Myelodysplastic Syndrome With Ring Sideroblasts·Matched via name phrase
- NCT07091370·NOT YET RECRUITING·Inaticabtagene Autoleucel Injection in the Treatment of Autoimmune Hemolytic Anemia After Three or More Lines of Therapy
Not reviewed·Conditions: AIHA - Cold Autoimmune Hemolytic Anemia·Matched via name phrase
- NCT06124586·RECRUITING·Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS)
Not reviewed·Conditions: Diabetic Foot · Diabetes Mellitus · Peripheral Arterial Disease · Diabetic Neuropathies·Matched via name phrase
- NCT07441525·RECRUITING·UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases
Not reviewed·Conditions: Autoimmune Hemolytic Anemia · Primary Immune Thrombocytopenic Purpura · Evans Syndrome·Matched via name phrase
- NCT07038330·NOT YET RECRUITING·DOSE FINDING PROSPECTIVE ANALYSIS AFTER HEART SURGERY for Sucrosomial Iron
Not reviewed·Conditions: Anemia·Matched via name phrase
- NCT07163390·NOT YET RECRUITING·Iron Deficiency Anemia in the Second and Third Trimester of Pregnancy
Not reviewed·Conditions: Anemia, Iron Deficiency · Pregnancy Anemia·Matched via name phrase
- NCT07079579·NOT YET RECRUITING·Enarodustat Tablets at Different Initial Doses for Anemia in Non-dialysis CKD Patients
Not reviewed·Conditions: Renal Anemia in Non-dialysis Chronic Kidney Disease·Matched via name phrase
- NCT07569172·NOT YET RECRUITING·Improved Child Nutrition and Development Through Social Transfers
Not reviewed·Conditions: Breastfeeding · Breastfeeding Education · Breastfeeding Duration · Breastfeeding Continuation·Matched via name phrase
- NCT06560164·RECRUITING·Restrictive Versus Liberal Thresholds for RBC Transfusion in ECMO
Not reviewed·Conditions: Transfusion · Red Blood Cell · Extracorporeal Membrane Oxygenation · Anemia·Matched via name phrase
- NCT06487299·NOT YET RECRUITING·Iron Administration Via Colonic TET Combined With WMT for ID
Not reviewed·Conditions: Iron Deficiency Anemia in Childbirth·Matched via name phrase
- NCT05708170·NOT YET RECRUITING·Impact of Intravenous Iron on Musculoskeletal Function in Older Adults
Not reviewed·Conditions: Iron Deficiency Anemia·Matched via name phrase
Observational and natural-history studies
22 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT06744283·RECRUITING·Experience and Management of Cancer Screening-Related Anxiety in Fanconi Anemia
Not reviewed·Conditions: Fanconi Anemia·Matched via name phrase
- NCT07005297·NOT YET RECRUITING·Clinical Genetics Branch Eligibility Screening Survey
Not reviewed·Conditions: Melanoma · Li-Fraumeni Syndrome · Pulmonary Blastoma · Chordoma·Matched via name phrase
- NCT03050268·RECRUITING·Familial Investigations of Childhood Cancer Predisposition
Not reviewed·Conditions: Acute Leukemia · Adenomatous Polyposis · Adrenocortical Carcinoma · AML·Matched via name phrase
- NCT00027274·RECRUITING·Cancer in Inherited Bone Marrow Failure Syndromes
Not reviewed·Conditions: Diamond Blackfan Anemia · Dyskeratosis Congenita · Fanconi Anemia · Shwachman Diamond Syndrome·Matched via name phrase
- NCT07527975·ENROLLING BY INVITATION·Long-Term Follow-up: Phase I/II Clinical Study to Evaluate the Safety and Efficacy of the Infusion of RP-L102
Not reviewed·Conditions: Fanconi Anemia·Matched via name phrase
- NCT07649031·RECRUITING·MRI as Noninvasive Innovative Approach in Detection and Monitoring of Malignant Oral Lesions in Fanconi Anemia Patients
Not reviewed·Conditions: Fanconi Anemia·Matched via name phrase
- NCT05687149·RECRUITING·Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia
Not reviewed·Conditions: Fanconi Anemia · Inherited Bone Marrow Failure Syndrome·Matched via name phrase
- NCT02720679·RECRUITING·Investigation of the Genetics of Hematologic Diseases
Not reviewed·Conditions: Bone Marrow Failure Syndromes · Erythrocyte Disorder · Leukocyte Disorder · Hemostasis·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 9 · after dedupe 7 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 7 · dropped 0 · fetched 2026-07-29
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (7)
- ctis·2024-511523-33-00·Authorised, ongoing·Long-Term Follow-up: Phase I/II clinical study to evaluate the safety and efficacy of the infusion of autologous CD34+ cells transduced with a lentiviral vector carrying the FANCA gene (orphan drug) in patients with Fanconi Anaemia Subtype A: FANCOLEN-I
skipped — LLM skipped (--skip-llm)
- ctis·2024-511477-29-00·Authorised, recruiting·AFAN trial. Phase Ib/II study to investigate the safety and efficacy of Afatinib when administered as therapy in Fanconi anemia patients with unresectable and / or metastatic locoregionally advanced squamous cell carcinoma of the oral cavity, oropharynx or hypopharynx or larynx
skipped — LLM skipped (--skip-llm)
- ctis·2023-506818-45-00·Expired·A modular, first time in human, open label, multiple dose, accelerated escalation with cohort expansion study of the safety and pharmacokinetics of intravenous infusion of CP-506, a tumor agnostic Hypoxia Activated Prodrug in patients with HRD/FAD solid tumors or tumor types with high incidence of HRD/FAD in monotherapy or in combination with carboplatin or patients with solid tumor and oligoprogressive disease receiving immune checkpoint inhibitors (ICI): a phase I-IIa clinical trial.
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN90362708·Recruiting·Bleximenib absorption, metabolism, and excretion in participants with acute leukemia
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN12278036·No longer recruiting·A study of bleximenib in combination with acute myeloid leukemia-directed therapies
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN11885863·No longer recruiting·Investigating the safety and efficacy of a Universal CAR-T cell immunotherapy in patients with relapse and refractory B-cell acute lymphoblastic leukemia and B lymphoblastic lymphoma
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN41980964·No longer recruiting·A Randomized Controlled Study in Newly Diagnosed Severe Aplastic Anemia Patients Receiving Antithymocyte Globulin (ATG), Cyclosporin A, with or without Granulocyte Colony Stimulating Factor (G-CSF)
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Fanconi anemia — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26Directly listed under NPRD Group 1.
Group 1 — one-time curative treatment
Up to ₹50 lakh per patient
Financial support for treatment at notified Centres of Excellence (figures evolved from the original ₹20 lakh Group-1 ceiling).
Policy figures change. Verify current MoHFW / CoE guidance before relying on any amount. Verify
Centres of Excellence (15)
- All India Institute of Medical Sciences (AIIMS) — New Delhi, Delhi
- Maulana Azad Medical College — New Delhi, Delhi
- Sanjay Gandhi Post Graduate Institute of Medical Sciences — Lucknow, Uttar Pradesh
- Post Graduate Institute of Medical Education and Research (PGIMER) — Chandigarh, Chandigarh
- Centre for DNA Fingerprinting & Diagnostics with Nizam’s Institute of Medical Sciences — Hyderabad, Telangana
- King Edward Memorial Hospital — Mumbai, Maharashtra
- Institute of Post-Graduate Medical Education and Research (IPGMER) — Kolkata, West Bengal
- Centre for Human Genetics with Indira Gandhi Hospital — Bengaluru, Karnataka
- Institute of Child Health and Hospital for Children (ICH & HC) — Chennai, Tamil Nadu
- All India Institute of Medical Sciences (AIIMS) — Jodhpur, Rajasthan
- Sree Avittam Thirunal Hospital (SAT), Government Medical College — Thiruvananthapuram, Kerala
- All India Institute of Medical Sciences (AIIMS) — Bhopal, Madhya Pradesh
- Regional Institute of Medical Sciences (RIMS) — Imphal, Manipur
- All India Institute of Medical Sciences (AIIMS) — Patna, Bihar
- Assam Medical College & Hospital — Dibrugarh, Assam
Voluntary contributions / crowdfunding (separate from CoE funding): https://rarediseases.mohfw.gov.in/
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
("Fanconi anemia" OR "Fanconi pancytopenia" OR "Fanconi's anemia" OR "Panmyelopathy, Fanconi" OR "pancytopenia, congenital" OR "primary erythroid hypoplasia") OR ("BRIP1" OR "BRIP1 syndrome" OR "BRIP1-related" OR "FANCM" OR "FANCM syndrome" OR "FANCM-related")ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Fanconi anemia" OR "Fanconi pancytopenia" OR "Fanconi's anemia" OR "Panmyelopathy, Fanconi" OR "pancytopenia, congenital" OR "primary erythroid hypoplasia"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 67 interventional · 22 observational · 2 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"anemia"
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-26T12:21:18.124Z
